View Item 

Show simple item record

Time and dosage effects of meprobamate on visual detection
dc.contributor.authorMiller, James G.en_US
dc.contributor.authorUhr, Leonarden_US
dc.contributor.authorClay, Margareten_US
dc.contributor.authorKristofferson, Alfred B.en_US
dc.contributor.authorPlatz, Arthuren_US
dc.date.accessioned2006-09-11T17:44:41Z
dc.date.available2006-09-11T17:44:41Z
dc.date.issued1964-01en_US
dc.identifier.citationPlatz, Arthur; Uhr, Leonard; Clay, Margaret; Miller, James G.; Kristofferson, Alfred B.; (1964). "Time and dosage effects of meprobamate on visual detection." Psychopharmacologia 6(1): 42-48. <http://hdl.handle.net/2027.42/46406>en_US
dc.identifier.issn1432-2072en_US
dc.identifier.issn0033-3158en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46406
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=5318330&dopt=citationen_US
dc.description.abstractSixteen male subjects, 21 years and older, were run in a doubleblind own-control design under three dosages of meprobamate (400, 800 and 1600 mg) and matching placebo, to determine response curves on a visual detection task over a four and one-half hour period, from 5:00 to 9:30 p.m. To control for possible daily cycle effects two additional runs under placebo and 1600 mg meprobamate were conducted from 8:00 a.m. to 12:30 p.m.en_US
dc.format.extent417758 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlagen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.titleTime and dosage effects of meprobamate on visual detectionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, USA; Central NP Research Laboratory, Veterans Administration Hospital, Perry Point, Maryland, USAen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, USAen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, USA; University of Cincinnati, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid5318330en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46406/1/213_2004_Article_BF00710913.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00710913en_US
dc.identifier.sourcePsychopharmacologiaen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
213_2004_Article_BF00710913.pdf
Size:
407.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.